GGrantIndex
← Search

PHASE I RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO ASSESS SAFETY, TOLERABILITY, AND PHARMACOKINETICS

$305,772N01FY2024NSNIH

Ppd Development Lp, Wilmington NC

Investigators

View original record on NIH RePORTER →